risks of glp 1 drugs Do The Benefits GLP-1 OutWeigh the Negatives? GI Adverse Effects of Glucagon-Like
Description
doi: 10.2337/dc16-0836
Nat Med 28(3):591598
Are There Specific Patient Populations Who Might Benefit Most from GLP-Agonists
Treat it as a supporting compound in a broader metabolic stack rather than a primary intervention
My prediction is we will be using individualized therapy for individualized people for CV risk reduction, he said.
Whats Emerging in Practice Outside of Trials GLP-1s live in the wildprescribed broadly, dosed variably, and sometimes obtained without medical oversight
